Transforming Breast Cancer Therapy: The Pivotal Role of Nanoparticles.

IF 3.3 4区 医学 Q3 CHEMISTRY, MEDICINAL
Lalit Kumar, Ritesh Rana, Isha Singh, Neelam Sharma, Vikas Aggarwal, Nisha Gupta, Vuluchala Jyothiraditya
{"title":"Transforming Breast Cancer Therapy: The Pivotal Role of Nanoparticles.","authors":"Lalit Kumar, Ritesh Rana, Isha Singh, Neelam Sharma, Vikas Aggarwal, Nisha Gupta, Vuluchala Jyothiraditya","doi":"10.2174/0115680266354524250424162638","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Globally, breast cancer (BC) affects a greater number of women than any other kind of cancer, and it is the second leading cause of death after lung cancer. The current standard of care for cancer treatment is the surgical excision of the malignant tumor followed by adjuvant therapy with chemotherapy or radiation. Regrettably, the side effects of radiation and chemotherapy frequently cause harm to healthy tissues and organs, hence limiting the effectiveness of these treatments in addressing BC. Recently, various nanoparticles (NPs) have been discovered and manufactured with the capacity to selectively target cancerous cells while minimizing harm to normal cells or organs. As a result, the utilization of NPs-mediated targeted drug delivery systems (DDS) has emerged as a promising method for treating BC.</p><p><strong>Objective: </strong>The primary aim of this review was to provide a concise overview of the function of different nanoparticles in the specific delivery of anticancer medications to eradicate breast cancer.</p><p><strong>Methods: </strong>The present review paper performed a literature inspection using several search engines such as PubMed, Google Scholar, and Science Direct.</p><p><strong>Results: </strong>In addition to their ability to selectively target tumor cells and minimize side effects, nanoparticles (NPs) possess other distinctive characteristics that make them highly desirable for cancer treatment. These include low toxicity, excellent compatibility, ease of preparation, high photoluminescence for in vivo bioimaging, and the capacity to efficiently load drugs due to their adjustable surface functionalities.</p><p><strong>Conclusion: </strong>This study provides a comprehensive examination of recent therapeutic studies that utilize various nanoparticle-mediated drug delivery systems as alternatives to established therapy techniques for breast cancer. This study will elucidate the importance of nanoparticle-mediated drug delivery systems (DDS) and provide a roadmap for identifying the optimal approach for future targeted drug delivery, specifically for the treatment of breast cancer.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current topics in medicinal chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0115680266354524250424162638","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Globally, breast cancer (BC) affects a greater number of women than any other kind of cancer, and it is the second leading cause of death after lung cancer. The current standard of care for cancer treatment is the surgical excision of the malignant tumor followed by adjuvant therapy with chemotherapy or radiation. Regrettably, the side effects of radiation and chemotherapy frequently cause harm to healthy tissues and organs, hence limiting the effectiveness of these treatments in addressing BC. Recently, various nanoparticles (NPs) have been discovered and manufactured with the capacity to selectively target cancerous cells while minimizing harm to normal cells or organs. As a result, the utilization of NPs-mediated targeted drug delivery systems (DDS) has emerged as a promising method for treating BC.

Objective: The primary aim of this review was to provide a concise overview of the function of different nanoparticles in the specific delivery of anticancer medications to eradicate breast cancer.

Methods: The present review paper performed a literature inspection using several search engines such as PubMed, Google Scholar, and Science Direct.

Results: In addition to their ability to selectively target tumor cells and minimize side effects, nanoparticles (NPs) possess other distinctive characteristics that make them highly desirable for cancer treatment. These include low toxicity, excellent compatibility, ease of preparation, high photoluminescence for in vivo bioimaging, and the capacity to efficiently load drugs due to their adjustable surface functionalities.

Conclusion: This study provides a comprehensive examination of recent therapeutic studies that utilize various nanoparticle-mediated drug delivery systems as alternatives to established therapy techniques for breast cancer. This study will elucidate the importance of nanoparticle-mediated drug delivery systems (DDS) and provide a roadmap for identifying the optimal approach for future targeted drug delivery, specifically for the treatment of breast cancer.

改变乳腺癌治疗:纳米颗粒的关键作用。
导言:在全球范围内,乳腺癌(BC)比任何其他类型的癌症影响更多的妇女,它是仅次于肺癌的第二大死亡原因。目前癌症治疗的护理标准是手术切除恶性肿瘤,然后辅以化疗或放疗。遗憾的是,放疗和化疗的副作用经常会对健康的组织和器官造成伤害,因此限制了这些治疗方法在治疗BC方面的有效性。最近,各种纳米粒子(NPs)已经被发现和制造,具有选择性靶向癌细胞的能力,同时最大限度地减少对正常细胞或器官的伤害。因此,利用nps介导的靶向药物递送系统(DDS)已成为治疗BC的一种有前途的方法。目的:本综述的主要目的是简要概述不同纳米颗粒在抗癌药物特异性递送中根除乳腺癌的功能。方法:本综述使用PubMed、b谷歌Scholar、Science Direct等多个搜索引擎进行文献检索。结果:除了选择性靶向肿瘤细胞和最小化副作用的能力外,纳米颗粒(NPs)还具有其他独特的特性,使其成为癌症治疗的理想选择。这些优点包括低毒性、良好的相容性、易于制备、高光致发光的体内生物成像,以及由于其可调节的表面功能而有效装载药物的能力。结论:本研究对最近利用各种纳米颗粒介导的药物输送系统作为乳腺癌现有治疗技术的替代品的治疗研究进行了全面的检查。这项研究将阐明纳米颗粒介导的药物传递系统(DDS)的重要性,并为确定未来靶向药物传递的最佳途径,特别是治疗乳腺癌提供路线图。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.40
自引率
2.90%
发文量
186
审稿时长
3-8 weeks
期刊介绍: Current Topics in Medicinal Chemistry is a forum for the review of areas of keen and topical interest to medicinal chemists and others in the allied disciplines. Each issue is solely devoted to a specific topic, containing six to nine reviews, which provide the reader a comprehensive survey of that area. A Guest Editor who is an expert in the topic under review, will assemble each issue. The scope of Current Topics in Medicinal Chemistry will cover all areas of medicinal chemistry, including current developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, compound diversity measurements, drug absorption, drug distribution, metabolism, new and emerging drug targets, natural products, pharmacogenomics, and structure-activity relationships. Medicinal chemistry is a rapidly maturing discipline. The study of how structure and function are related is absolutely essential to understanding the molecular basis of life. Current Topics in Medicinal Chemistry aims to contribute to the growth of scientific knowledge and insight, and facilitate the discovery and development of new therapeutic agents to treat debilitating human disorders. The journal is essential for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important advances.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信